1[1]Brenner BM, Cooper ME, Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New Engl J Med, 2001, 345(12): 861-869
2[2]Cinotti GA, Zucchelli PC. Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies. Nephrol Dial Transplant, 2001, 16(5): 961-966
3[3]Usta M, Dilek K, Yavuz M, et al. Anti-proteinuric effect of angiotensin II receptor antagonist losartan in cases with glomerular lesions. Clin Nephrol, 2001, 55(3): 260-262
8Burns KD, Angiotensin Ⅱ and its receptors in the diabetic kidney [J]. Am J kidney Dis,2000,36(3) :449-467.
9Taal MW, Brenner BM.Renoprotective benefits of RAS inhibition,from ACEI to angiotensin Ⅱ antagonists[J].Kidney Int,2000,57:1803-1817.
10Usta M, Dilek K, Yavuz M, et al. Anti-proteinuric effect of angiotensin Ⅱ receptor antagonist Losartan in cases with glomerular lesions[J].Clin Nephrol,2001,55(3):260-262.
